Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ont.
Can J Ophthalmol. 2010 Aug;45(4):342-51. doi: 10.3129/i10-070.
Retinal degeneration encompasses a constellation of common pathologies for which there is no regenerative treatment. Vision loss has a devastating impact on quality of life and activities of daily living. Pharmacologic treatments serve to stave off disease progression but do not represent a restorative approach. Cellular transplantation is considered to be a promising approach for future therapy for retinal degeneration. There are, however, significant barriers that must be overcome if cell transplantation is to become a clinical reality. In this review, we focus on the need for a cellular replacement therapy for retinal disease and the promise of stem cells as candidate cellular therapeutics. In particular, we discuss the origins of stem cells in the retina, the discovery and characterization of retinal stem cells isolated from adult humans, and their transplantation potential and clinical implications.
视网膜变性包括一系列常见的病理,目前尚无再生治疗方法。视力丧失对生活质量和日常生活活动有毁灭性的影响。药物治疗可以延缓疾病的进展,但不能代表一种恢复性的方法。细胞移植被认为是未来治疗视网膜变性的一种有前途的方法。然而,如果细胞移植要成为临床现实,还必须克服许多重大障碍。在这篇综述中,我们重点讨论了对视网膜疾病的细胞替代治疗的需求,以及干细胞作为候选细胞治疗的前景。特别是,我们讨论了视网膜中干细胞的起源,从成人分离的视网膜干细胞的发现和特性,以及它们的移植潜力和临床意义。